ReviewWorld journal of gastroenterology2006
Cardiopulmonary complications in chronic liver disease.
Review in World journal of gastroenterology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 67 citations in OpenAlex.
- Article
- Review
- Shortness of breath due to portopulmonary hypertension and hepatopulmonary syndrome: diagnostic challenges and complex management approach in frail patients.Clinical medicine (London, England) · 2022Article
- Taurine mitigates cirrhosis-associated heart injury through mitochondrial-dependent and antioxidative mechanisms.Clinical and experimental hepatology · 2020Article
- Vasoplegia after implantation of a continuous flow left ventricular assist device: incidence, outcomes and predictors.BMC anesthesiology · 2018Article
- Managing portal hypertension in patients with liver cirrhosis.F1000Research · 2018Review
- Anaesthesia and intensive care for simultaneous liver-kidney transplantation: A single-centre experience with 12 recipients.Indian journal of anaesthesia · 2016Article
- Cerebral air embolism and subsequent transient neurologic abnormalities in a liver transplant recipient following the removal of the pulmonary artery catheter from the central venous access device: a case report.Korean journal of anesthesiology · 2016Article
- Bioreactance Is Not Interchangeable with Thermodilution for Measuring Cardiac Output during Adult Liver Transplantation.PloS one · 2015Observational
- Cirrhotic cardiomyopathy: a cardiologist's perspective.World journal of gastroenterology · 2014Review
- Recent advances in the diagnosis and management of cirrhosis-associated cardiomyopathy in liver transplant candidates: advanced echo imaging, cardiac biomarkers, and advanced heart failure therapies.Clinical Medicine Insights. Cardiology · 2014Review
- Diastolic dysfunction and severity of cirrhosis in nonalcoholic cirrhotic patients.International journal of hepatology · 2013Article
- Portopulmonary hypertension and hepatopulmonary syndrome: a clinician-oriented overview.European respiratory review : an official journal of the European Respiratory Society · 2012Article
- Pulmonary complications in cirrhotic candidates for liver transplantation.Hepatitis monthly · 2010Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Patients with cirrhosis and portal hypertension exhibit characteristic cardiovascular and pulmonary hemodynamic changes. A vasodilatatory state and a hyperdynamic circulation affecting the cardiac and pulmonary functions dominate the circulation. The recently defined cirrhotic cardiomyopathy may affect systolic and diastolic functions, and imply electromechanical abnormalities. In addition, the baroreceptor function and regulation of the circulatory homoeostasis is impaired. Pulmonary dysfunction involves diffusing abnormalities with the development of the hepatopulmonary syndrome and portopulmonary hypertension in some patients. Recent research has focused on the assertion that the hemodynamic and neurohumoral dysregulation are of major importance for the development of the cardiovascular and pulmonary complications in cirrhosis. This aspect is important to take into account in the management of these patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.